Psychological Empowerment Program in Preventing Postpartum Depression Among Pregnant Women

June 4, 2026 updated by: Miranie Safaringga

The Effectiveness of Psychological Empowerment Program in Preventing Postpartum Depression Among Pregnant Women in Indonesia: A Randomized Controlled Trial

The goal of this clinical trial is to prevent postpartum depression in pregnant women. The main questions it aims to answer are:

  1. Does the Psychological Empowerment program prevent postpartum depression at 6 weeks after delivery?
  2. Does the Psychological Empowerment program improve self-control of the postpartum women at 6 weeks after delivery?
  3. Does the Psychological Empowerment program improve the self-efficacy of postpartum women at 6 weeks after delivery?
  4. Does the Psychological Empowerment program provide a tendency to have adaptive coping strategies in women 6 weeks after delivery?

Researchers will compare the intervention group to a control group with no intervention (routine care) to see if the psychological empowerment program can prevent postpartum depression at 6 weeks after delivery.

Participants in the intervention group will :

  • receive 5 sessions in 3 weeks ( 2 sessions per week)
  • get follow-up at 2 weeks and 6 weeks after delivery

Study Overview

Status

Active, not recruiting

Detailed Description

Postpartum depression (PPD) is a common mental health problem that affects women during pregnancy and after childbirth. Women with postpartum depression may experience persistent sadness, anxiety, stress, low self-confidence, sleep disturbances, difficulty bonding with their baby, and emotional distress that can interfere with daily functioning and family relationships. In Indonesia, the prevalence of postpartum depression remains high, while preventive mental health services for pregnant women are still limited. Maternal care services primarily focus on physical health, with minimal attention given to psychological preparation and emotional well-being during pregnancy.

This study aims to evaluate the effectiveness of a Psychological Empowerment Program in preventing postpartum depression among pregnant women in Indonesia. The program is based on Zimmerman's Psychological Empowerment Theory and is designed to strengthen women's perceived control, self-efficacy, coping behaviour during pregnancy and the transition to motherhood.

This research will use a randomized controlled trial (RCT) design. Eligible pregnant women in their third trimester, together with their partners, will be randomly assigned to either an intervention group or a control group. Participants in the intervention group will receive the Psychological Empowerment Program in addition to routine antenatal care, while participants in the control group will receive standard antenatal and postnatal care only.

The intervention consists of structured weekly sessions delivered through interactive discussions, guided activities, emotional coping exercises, communication training, problem-solving activities, and empowerment-focused education. Topics include understanding emotional changes during pregnancy, increasing self-confidence in motherhood, improving coping strategies,, and building practical parenting skills. Sessions will be facilitated by trained healthcare professionals, including midwives, psychologists, and mental health nurses. (facilitator training will be conducted before the intervention)

The study will measure depressive symptoms, self-efficacy, perceived control, and coping strategies before the intervention, after completion of the program, and during the postpartum follow-up period. Standardized questionnaires, including the Edinburgh Postnatal Depression Scale (EPDS), General Self-Efficacy Scale (GSES), Pearlin Mastery Scale, and Brief COPE Inventory, will be used to evaluate outcomes.

The findings from this study are expected to provide evidence for culturally appropriate and empowerment-based strategies to prevent postpartum depression in Indonesia. The program may contribute to improving maternal mental health services, strengthening family support systems, and promoting healthier outcomes for mothers, infants, and families.

Study Type

Interventional

Enrollment (Estimated)

92

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • West Sumatra
      • Padang, West Sumatra, Indonesia, 25163
        • Primary Health Centre Lubuk Begalung

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria :

  • Pregnant women between 30-33 weeks of gestation
  • Primiparous
  • Age 18 years and above
  • Able to read and communicate in the local language
  • Living with a partner

Exclusion Criteria:

  • History of diagnosed psychiatric illness (e.g., bipolar disorder, schizophrenia)
  • High-risk pregnancy conditions that require specialized medical care
  • Unwilling or unable to commit to the intervention schedule

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
Participants assigned to the intervention group will receive the Psychological Empowerment Program in addition to routine care. A total of 46 pregnant women will be divided into four groups based on their time convenience, with each group consisting of 10-12 women. It would be beneficial to increase intervention fidelity and make it easier for the researcher to follow up at the time, as well as provide opportunities for more interactions within the peer group. Each group will receive the intervention at a different time. The program consists of structured 5 sessions in 3 weekly sessions (2 sessions in one week). Sessions include psychoeducation, guided discussions, emotional coping exercises, communication and conflict resolution training, problem-solving activities, and practical parenting preparation The intervention is delivered by trained midwives, psychologists, and mental health nurses, through interactive workshops and supportive group activities.

The Psychological Empowerment Program is a theory-based behavioura intervention designed for pregnant women to prevent postpartum depression. The intervention is based on Zimmerman's Psychological Empowerment Theory and focuses on strengthening perceived control, self-efficacy, and coping behaviour during pregnancy and the transition to motherhood.

The program consists of 5 structured sessions conducted in 3 weeks a, each lasting approximately 90 minutes. Sessions are delivered in small groups (12 participants each group) through interactive workshops, guided discussions, role-play activities, coping skills training, communication exercises, problem-solving simulations, and reflective journaling. The intervention includes psychoeducation on postpartum depression, stress management techniques, emotional regulation strategies, assertive communication training, and practical preparation for parenting challenges.

Other Names:
  • PEP
No Intervention: Control Group
Participants assigned to the control group will receive routine antenatal and postnatal care provided by the healthcare facility, including standard health education and pregnancy monitoring, without the structured psychological empowerment intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postpartum Depression
Time Frame: - From enrollment to the end of the intervention will take 3 weeks (during pregnancy, participants' gestation age in the range 35-38 weeks) - Follow-up 1: at 2 weeks after delivery - Follow-up 2: at 6 weeks after delivery (each participant may vary)
Postpartum Depression Symptoms (EPDS) The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report questionnaire used to assess depressive symptoms during the perinatal period. Each item is scored on a 4-point scale (0-3), with total scores ranging from 0 to 30. Higher scores indicate more severe depressive symptoms. A score of 13 or higher is considered indicative of probable postpartum depression and suggests the need for further psychological assessment. Lower scores represent better mental health outcomes and fewer depressive symptoms.
- From enrollment to the end of the intervention will take 3 weeks (during pregnancy, participants' gestation age in the range 35-38 weeks) - Follow-up 1: at 2 weeks after delivery - Follow-up 2: at 6 weeks after delivery (each participant may vary)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived Control
Time Frame: - From enrollment to the end of the intervention will take 3 weeks (during pregnancy, participants' gestation age in the range 35-38 weeks) - Follow-up 1: at 2 weeks after delivery - Follow-up 2: at 6 weeks after delivery (each participant may vary)
Perceived Control measure using Pearlin Mastery Scale The Pearlin Mastery Scale is a 7-item questionnaire that assesses an individual's perceived sense of control over life circumstances. Items are rated on a 4-point Likert scale ranging from 1 ("Strongly agree") to 4 ("Strongly disagree"). Total scores range from 7 to 28. Higher scores indicate a stronger sense of personal mastery and perceived control over life events, whereas lower scores indicate feelings of helplessness and reduced control.
- From enrollment to the end of the intervention will take 3 weeks (during pregnancy, participants' gestation age in the range 35-38 weeks) - Follow-up 1: at 2 weeks after delivery - Follow-up 2: at 6 weeks after delivery (each participant may vary)
Self Efficacy
Time Frame: - From enrollment to the end of the intervention will take 3 weeks (during pregnancy, participants' gestation age in the range 35-38 weeks) - Follow-up 1: at 2 weeks after delivery - Follow-up 2: at 6 weeks after delivery (each participant may vary)
Self-Efficacy measure used The General Self-Efficacy Scale (GSES). GSES is a 10-item self-report instrument measuring an individual's confidence in managing stressful situations and overcoming challenges. Each item is rated on a 4-point Likert scale ranging from 1 ("Not at all true") to 4 ("Exactly true"). Total scores range from 10 to 40. Higher scores indicate greater self-efficacy and stronger confidence in one's ability to cope with difficulties, while lower scores indicate lower perceived self-efficacy.
- From enrollment to the end of the intervention will take 3 weeks (during pregnancy, participants' gestation age in the range 35-38 weeks) - Follow-up 1: at 2 weeks after delivery - Follow-up 2: at 6 weeks after delivery (each participant may vary)
Coping Behavior
Time Frame: - From enrollment to the end of the intervention will take 3 weeks (during pregnancy, participants' gestation age in the range 35-38 weeks) - Follow-up 1: at 2 weeks after delivery - Follow-up 2: at 6 weeks after delivery (each participant may vary)
Coping Behavior will asess usind The Brief COPE Inventory. The Brief COPE Inventory is a 28-item self-report instrument used to assess adaptive and maladaptive coping strategies. Each item is scored on a 4-point Likert scale ranging from 1 ("I haven't been doing this at all") to 4 ("I've been doing this a lot"). Subscale scores are calculated for different coping domains. Higher scores on adaptive coping domains (e.g., active coping, emotional support, positive reframing) indicate better coping abilities, while higher scores on maladaptive coping domains (e.g., denial, behavioral disengagement, self-blame) indicate less effective coping strategies.
- From enrollment to the end of the intervention will take 3 weeks (during pregnancy, participants' gestation age in the range 35-38 weeks) - Follow-up 1: at 2 weeks after delivery - Follow-up 2: at 6 weeks after delivery (each participant may vary)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yu Ying Lu, Professor, National Taipei University of Nursing and Health Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 10, 2026

Primary Completion (Estimated)

August 25, 2026

Study Completion (Estimated)

August 30, 2026

Study Registration Dates

First Submitted

May 28, 2026

First Submitted That Met QC Criteria

June 4, 2026

First Posted (Actual)

June 9, 2026

Study Record Updates

Last Update Posted (Actual)

June 9, 2026

Last Update Submitted That Met QC Criteria

June 4, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All IPD that underlie results in a publication will be shared. The shared datasets may include participant demographic characteristics, baseline measures, intervention allocation, and outcome data collected at all study time points, including scores on the Edinburgh Postnatal Depression Scale (EPDS), the General Self-Efficacy Scale (GSES), the Pearlin Mastery Scale, and the Brief COPE Inventory. Data will be provided in a de-identified format to protect participant confidentiality.

IPD Sharing Time Frame

De-identified individual participant data (IPD) and supporting documentation will be available beginning 6 months after publication of the primary study results and will remain available for 5 years following publication.

IPD Sharing Access Criteria

Data will be available to qualified researchers who provide a methodologically sound research proposal. Requests will be reviewed by the principal investigator. Data will be shared after approval of a data use agreement designed to protect participant confidentiality.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postpartum Depression

Clinical Trials on Psychological Empowerment Program

Subscribe